39037560|t|NMN Synbiotics: A Multifaceted Therapeutic Approach for Alzheimer's Disease.
39037560|a|With the aging global population, Alzheimer's disease (AD) has become a significant social and economic burden, necessitating the development of novel therapeutic strategies. This study investigates the therapeutic potential of nicotinamide mononucleotide (NMN) synbiotics, a combination of NMN, Lactiplantibacillus plantarum CGMCC 1.16089, and lactulose, in mitigating AD pathology. APP/PS1 mice were supplemented with NMN synbiotics and compared against control groups. The effects on amyloid-beta (Abeta) deposition, intestinal histopathology, tight junction proteins, inflammatory cytokines, and reactive oxygen species (ROS) levels were assessed. NMN synbiotics intervention significantly reduced Abeta deposition in the cerebral cortex and hippocampus by 67% and 60%, respectively. It also ameliorated histopathological changes in the colon, reducing crypt depth and restoring goblet cell numbers. The expression of tight junction proteins Claudin-1 and ZO-1 was significantly upregulated, enhancing intestinal barrier integrity. Furthermore, NMN synbiotics decreased the expression of proinflammatory cytokines IL-1beta, IL-6, and TNF-alpha, and reduced ROS levels, indicative of attenuated oxidative stress. The reduction in Abeta deposition, enhancement of intestinal barrier function, decrease in neuroinflammation, and alleviation of oxidative stress suggest that NMN synbiotics present a promising therapeutic intervention for AD by modulating multiple pathological pathways. Further research is required to elucidate the precise mechanisms, particularly the role of the NLRP3 inflammasome pathway, which may offer a novel target for AD treatment.
39037560	0	3	NMN	Chemical	MESH:D009537
39037560	56	75	Alzheimer's Disease	Disease	MESH:D000544
39037560	111	130	Alzheimer's disease	Disease	MESH:D000544
39037560	132	134	AD	Disease	MESH:D000544
39037560	305	332	nicotinamide mononucleotide	Chemical	MESH:D009537
39037560	334	337	NMN	Chemical	MESH:D009537
39037560	368	371	NMN	Chemical	MESH:D009537
39037560	422	431	lactulose	Chemical	MESH:D007792
39037560	447	449	AD	Disease	MESH:D000544
39037560	461	464	APP	Gene	351
39037560	465	468	PS1	Gene	5663
39037560	469	473	mice	Species	10090
39037560	497	500	NMN	Chemical	MESH:D009537
39037560	564	576	amyloid-beta	Gene	351
39037560	578	583	Abeta	Gene	351
39037560	677	700	reactive oxygen species	Chemical	MESH:D017382
39037560	702	705	ROS	Chemical	MESH:D017382
39037560	729	732	NMN	Chemical	MESH:D009537
39037560	779	784	Abeta	Gene	351
39037560	1023	1032	Claudin-1	Gene	9076
39037560	1037	1041	ZO-1	Gene	7082
39037560	1126	1129	NMN	Chemical	MESH:D009537
39037560	1195	1203	IL-1beta	Gene	3553
39037560	1205	1209	IL-6	Gene	3569
39037560	1215	1224	TNF-alpha	Gene	7124
39037560	1238	1241	ROS	Chemical	MESH:D017382
39037560	1310	1315	Abeta	Gene	351
39037560	1384	1401	neuroinflammation	Disease	MESH:D000090862
39037560	1452	1455	NMN	Chemical	MESH:D009537
39037560	1516	1518	AD	Disease	MESH:D000544
39037560	1660	1665	NLRP3	Gene	114548
39037560	1723	1725	AD	Disease	MESH:D000544
39037560	Negative_Correlation	MESH:D007792	MESH:D000544
39037560	Negative_Correlation	MESH:D009537	3553
39037560	Negative_Correlation	MESH:D009537	351
39037560	Negative_Correlation	MESH:D009537	MESH:D000090862
39037560	Negative_Correlation	MESH:D009537	3569
39037560	Positive_Correlation	MESH:D009537	9076
39037560	Negative_Correlation	MESH:D009537	7124
39037560	Positive_Correlation	MESH:D009537	7082
39037560	Association	MESH:D000544	114548
39037560	Cotreatment	MESH:D007792	MESH:D009537
39037560	Negative_Correlation	MESH:D009537	MESH:D017382
39037560	Negative_Correlation	MESH:D009537	MESH:D000544

